Abstract |
We report two cases of severe bronchopneumonia due to influenza A (H3N2) virus. The severity of the disease necessitated initiation of empiric therapy based on the present illness and clinical data on admission. Both patients were improved by artificial ventilation with positive end-expiratory pressures and administration of broad spectrum antibiotics and corticosteroids before confirming the diagnosis of viral bronchopneumonia using viral culture and serological tests. Within 24 hours, influenza A (H3N2) virus was identified by amplification of the pathogen genes by reverse transcription polymerase chain reaction (RT-PCR) using the stored bronchoalveolar lavage (BAL) fluids of both cases. This suggests that a combination of detection methods of pathogens using RT-PCR and BAL fluid will facilitate determination of rational treatment aimed at influenza A virus.
|
Authors | M Doi, S Takao, K Kaneko, S Karakawa, S Ishihara, Y Awaya, M Kuwabara, S Ishioka, M Yamakido |
Journal | Internal medicine (Tokyo, Japan)
(Intern Med)
Vol. 40
Issue 1
Pg. 61-7
(Jan 2001)
ISSN: 0918-2918 [Print] Japan |
PMID | 11201374
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Cephalosporins
- RNA, Viral
- Fosfomycin
- Clindamycin
- Betamethasone
- Minocycline
- flomoxef
- Methylprednisolone
|
Topics |
- Aged
- Antibiotic Prophylaxis
- Betamethasone
(therapeutic use)
- Bronchoalveolar Lavage Fluid
(virology)
- Bronchopneumonia
(etiology, therapy, virology)
- Cephalosporins
(therapeutic use)
- Clindamycin
(therapeutic use)
- Combined Modality Therapy
- Drug Therapy, Combination
(therapeutic use)
- Fosfomycin
(therapeutic use)
- Humans
- Influenza A Virus, H3N2 Subtype
- Influenza A virus
(genetics, isolation & purification)
- Male
- Methylprednisolone
(therapeutic use)
- Middle Aged
- Minocycline
(therapeutic use)
- Pneumonia, Viral
(etiology, therapy, virology)
- Positive-Pressure Respiration
- RNA, Viral
(analysis)
- Respiration, Artificial
- Reverse Transcriptase Polymerase Chain Reaction
|